The Q1 beat and maintained guidance provide near-term relief, but the underlying business continues to shrink (revenue -4%, EBITDA -40%). Monitor any updates from the strategic review as the primary catalyst. Q2 guidance implies further deterioration, so expect volatility around guidance execution.
Price Chart
Executive Summary
FMC reported Q1 2026 adjusted loss per share of -$0.23, beating consensus of -$0.38, on revenue of $762M (ex-India) vs $742.4M estimate. The company reaffirmed its full-year 2026 guidance, which implies continued revenue and EBITDA declines. The strategic review announced in February 2026 remains ongoing.
Key Financial Metrics
Key Facts
- Q1 2026 adjusted loss per share -$0.23 vs consensus -$0.38 (beat by $0.15)
- Q1 2026 revenue ex-India $762M, down 4% YoY, above $742.4M consensus
- Full-year 2026 guidance maintained: revenue $3.6B-$3.8B, adjusted EBITDA $670M-$730M, adjusted EPS $1.63-$1.89
- Q2 2026 outlook: revenue $850M-$900M, adjusted EPS $0.16-$0.26 (down ~70% YoY at midpoint)
- Strategic review including potential sale of the company is progressing
- Adjusted EBITDA of $72M was down 40% YoY and above the high end of guidance range
Financial Impact
Adjusted EPS beat of $0.15 vs consensus (-$0.23 vs -$0.38), revenue beat of ~$20M vs consensus, but both down YoY
Risk Factors
- Continued revenue and EBITDA declines in 2026
- Uncertainty regarding the strategic review outcome (potential sale at unfavorable terms)
- High debt load ($4.5B total debt) and negative free cash flow
- Post-patent erosion of Rynaxypyr franchise
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000037785-26-000083 |
| Document: fmc-20260429.htm | 0000037785-26-000083 |
| Document: 0000037785-26-000083-index-headers.html | 0000037785-26-000083 |
| Document: 0000037785-26-000083-index.html | 0000037785-26-000083 |
| Document: 0000037785-26-000083.txt | 0000037785-26-000083 |
| 8-K Data (Synthetic) | 0000037785-26-000083 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 23, 2026 10w ago | Press Release | $11.30 $11.02 | ▼ −2.48% | ▼ −6.10% | $8.52 (−24.56%) |
Jul 1, 2026 13w ago | 8-K | $10.95 $10.01 | ▼ −8.58% | ▼ −6.40% | $8.52 (−22.15%) |
Jun 23, 2026 14w ago | 8-K | $11.32 $11.78 | ▲ +4.06% | ▲ +2.13% | $8.52 (−24.69%) |
Jun 12, 2026 16w ago | Institutional Cluster | $11.85 $10.91 | ▼ −7.93% | ▼ −9.71% | $8.52 (−28.06%) |
Jun 5, 2026 16w ago | 8-K | $11.10 $11.38 | ▲ +2.52% | ▲ +0.89% | $8.52 (−23.20%) |
May 21, 2026 19w ago | 8-K | $13.11 $11.13 | ▼ −15.12% | ▼ −13.71% | $8.52 (−34.97%) |
May 19, 2026 19w ago | 8-K | $12.76 $11.98 | ▼ −6.11% | ▼ −7.10% | $8.52 (−33.19%) |
Apr 29, 2026 22w ago | 8-K | $15.38 $13.57 | ▼ −11.77% | ▼ −16.74% | $8.52 (−44.57%) |
Apr 29, 2026 22w ago | 8-K | $15.38 $13.57 | ▼ −11.77% | ▼ −16.74% | $8.52 (−44.57%) |
Apr 27, 2026 22w ago | DEFA14A | $15.56 $12.98 | ▼ −16.58% | ▼ −21.54% | $8.52 (−45.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access